相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Duration and Type of Surgical Prophylaxis With Antimicrobial-Associated Adverse Events
Westyn Branch-Elliman et al.
JAMA SURGERY (2019)
AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis
Cynthia W. Ko et al.
GASTROENTEROLOGY (2019)
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Changes in Prevalence of Health Care-Associated Infections in US Hospitals
S. S. Magill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease
Harminder Singh et al.
GASTROENTEROLOGY (2017)
Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients
Tonya L. Scardina et al.
PHARMACOTHERAPY (2017)
Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity
Hua Yu et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study
Harry Sokol et al.
DIGESTIVE AND LIVER DISEASE (2017)
Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study
Roshan Razik et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Clostridium difficile colitis: pathogenesis and host defence
Michael C. Abt et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: A Systematic Review and Meta-analysis
Luis Furuya-Kanamori et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2015)
Corticosteroid use is associated with a reduced incidence of Clostridium difficile-associated diarrhea: A retrospective cohort study
Amy L. Wojciechowski et al.
ANAEROBE (2014)
Markers of Intestinal Inflammation, Not Bacterial Burden, Correlate With Clinical Outcomes in Clostridium difficile Infection
Rana E. El Feghaly et al.
CLINICAL INFECTIOUS DISEASES (2013)
Role of Interleukin 23 Signaling in Clostridium difficile Colitis
Erica L. Buonomo et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections
S. Schneeweiss et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?
Irfan A. Dhalla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Antiinflammatory action of glucocorticoids - New mechanisms for old drugs
T Rhen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids
D Czock et al.
CLINICAL PHARMACOKINETICS (2005)
Dose equivalency evaluation of major corticosteroids: Pharmacokinetics and cell trafficking and cortisol dynamics
DE Mager et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
WA Faubion et al.
GASTROENTEROLOGY (2001)
分享论文
